Many insurance stocks have been sold off recently by investors due to fears over the credit crunch and expectations that softer insurance market pricing will further reduce insurers’ profitability.
One insurer which I think represents good value, despite these headwinds, is HCC Insurance. HCC insurance (HCC, Financial) is AA rated by S&P and began operations in 1974. It has offices in the US, Europe and the UK.
HCC Insurance is truly a specialty insurer with an excellent franchise . They don’t write general liability or workers compensation insurance. They write numerous products including directors and officers liability, aircraft insurance, marine insurance and life,accident and health products. Many of the insurance products fall outside the standard market so are subject to less price competition. HCC estimate that over 60% of their products fall outside the standard insurance cycle.
Historically, due to its specialty focus and underwriting discipline, HCC has maintained a combined ratio well below the industry average and their loss reserving has been overly conservative with loss redundancies consistently reported with one or two exceptional years. Since 1981, HCC has only made an underwriting loss on only two occasions in 2001 (combined ratio was 101.8%) which included $22 million in losses from the World Trade Centre attacks and 1999(combined ratio was 104.1%).
One way HCC maintains above average profitability is by keeping a solid grip on their underwriting. HCC will buy the Managing General Agents or MGAs that they use. This way they have more control over terms and the pricing of policies.
Around 12 months ago HCC was mired in controversy over the manipulation of options grants which cost the job of former CEO Stephen Way. The ultimate cost of these grants was minimal. A recent legal case resulting from this options was settled for $3 million , which was fairly immaterial. The loss of Stephen Way was far more damaging as he spearheaded HCC since founding the company in 1974 and has been instrumental in HCC’s success. Nevertheless, many of the key operating officers who have been part of HCC’s growth over many years including Frank Bramanti ,current CEO, and John Molbeck, current Chief Operating Officer, remain with HCC. Further, HCC has an experienced management team in each of its operating subsidiaries. Their de-centralised management structure is a key strength for HCC.
HCC under current management has been hitting on all cylinders over 2007. Net earnings are up 13% to $295 mil for the nine months ended 30 September 2007 from $261 million in nine months ended 30 September 2006. The GAAP combined ratio for 2007 and 2006 has been an excellent 83%. On a trailing twelve month basis their earnings are around $370 million.
Frank Bramanti has maintained disciplined & patient approach on the issue of making acquisitions , insisting they will wait for the right opportunities to come up as the insurance cycle continues to soften, and they will not over-pay. In the meantime, HCC continue to pay down their debt and build their cash reserves. Recently they acquired Mulitnational Underwriters (MNU) further adding to their health insurance arm and which will add $40 million in premiums to their business. They aso recently rceived approval for a new Lloyds syndicate platform to help expand their global insurance products.
HCC has a very conservative balance sheet, their fixed income investment portfolio had an average AAA rating. They have debt to capital of just 11.6%. Their fixed income investments are managed by New England Asset Management , a subsidiary of Berkshire Hathaway. They have just $20 million, less than 1% of shareholder equity, in subprime and Alt A bonds which are rated AAA and have not been subject to downgrade. They own no CDOs or CLOs.
HCC valuation looks reasonable and in my view is now being priced both for a recession and a soft insurance market (not to say the share price can’t go lower …all the better!). HCC Insurance has a market cap of around $3.1 billion or $27 per share, around 1.28x my estimate of closing book value of $21 for 2007. This is the one of the lowest price to book value ratios that HCC has traded at in the last decade. Its earnings for this year will be around $3.30 per share ,so the PE ratio is a modest 8x and pays a 1.6% dividend. A lot of downside risks have been priced into this company. Despite options related sales by two directors, insiders have been buying shares over the last 6 months. Of note, John Molbeck ,COO, bought $418K in stock on open market in August at around $27-$28 per share and during January Edward Ellis, Chief Financial Officer, exercised over $1 million in options at $18 per share and has not sold any shares after that exercise.
Finally,HCC Insurance could also become an acquisition target for a large insurance company such as AIG or foreign insurer such as Allianz, given the unique franchise HCC holds in the specialty insurance market. I would expect HCC would command a price to book value of 2x book or $42 per share if sold on a private market basis.
Disclosure: I own shares in HCC Insurance(HCC)
Disclaimer: The opinions expressed by the author’s own views and are not intended as investment advice and should not be relied upon as investment advice.
One insurer which I think represents good value, despite these headwinds, is HCC Insurance. HCC insurance (HCC, Financial) is AA rated by S&P and began operations in 1974. It has offices in the US, Europe and the UK.
HCC Insurance is truly a specialty insurer with an excellent franchise . They don’t write general liability or workers compensation insurance. They write numerous products including directors and officers liability, aircraft insurance, marine insurance and life,accident and health products. Many of the insurance products fall outside the standard market so are subject to less price competition. HCC estimate that over 60% of their products fall outside the standard insurance cycle.
Historically, due to its specialty focus and underwriting discipline, HCC has maintained a combined ratio well below the industry average and their loss reserving has been overly conservative with loss redundancies consistently reported with one or two exceptional years. Since 1981, HCC has only made an underwriting loss on only two occasions in 2001 (combined ratio was 101.8%) which included $22 million in losses from the World Trade Centre attacks and 1999(combined ratio was 104.1%).
One way HCC maintains above average profitability is by keeping a solid grip on their underwriting. HCC will buy the Managing General Agents or MGAs that they use. This way they have more control over terms and the pricing of policies.
Around 12 months ago HCC was mired in controversy over the manipulation of options grants which cost the job of former CEO Stephen Way. The ultimate cost of these grants was minimal. A recent legal case resulting from this options was settled for $3 million , which was fairly immaterial. The loss of Stephen Way was far more damaging as he spearheaded HCC since founding the company in 1974 and has been instrumental in HCC’s success. Nevertheless, many of the key operating officers who have been part of HCC’s growth over many years including Frank Bramanti ,current CEO, and John Molbeck, current Chief Operating Officer, remain with HCC. Further, HCC has an experienced management team in each of its operating subsidiaries. Their de-centralised management structure is a key strength for HCC.
HCC under current management has been hitting on all cylinders over 2007. Net earnings are up 13% to $295 mil for the nine months ended 30 September 2007 from $261 million in nine months ended 30 September 2006. The GAAP combined ratio for 2007 and 2006 has been an excellent 83%. On a trailing twelve month basis their earnings are around $370 million.
Frank Bramanti has maintained disciplined & patient approach on the issue of making acquisitions , insisting they will wait for the right opportunities to come up as the insurance cycle continues to soften, and they will not over-pay. In the meantime, HCC continue to pay down their debt and build their cash reserves. Recently they acquired Mulitnational Underwriters (MNU) further adding to their health insurance arm and which will add $40 million in premiums to their business. They aso recently rceived approval for a new Lloyds syndicate platform to help expand their global insurance products.
HCC has a very conservative balance sheet, their fixed income investment portfolio had an average AAA rating. They have debt to capital of just 11.6%. Their fixed income investments are managed by New England Asset Management , a subsidiary of Berkshire Hathaway. They have just $20 million, less than 1% of shareholder equity, in subprime and Alt A bonds which are rated AAA and have not been subject to downgrade. They own no CDOs or CLOs.
HCC valuation looks reasonable and in my view is now being priced both for a recession and a soft insurance market (not to say the share price can’t go lower …all the better!). HCC Insurance has a market cap of around $3.1 billion or $27 per share, around 1.28x my estimate of closing book value of $21 for 2007. This is the one of the lowest price to book value ratios that HCC has traded at in the last decade. Its earnings for this year will be around $3.30 per share ,so the PE ratio is a modest 8x and pays a 1.6% dividend. A lot of downside risks have been priced into this company. Despite options related sales by two directors, insiders have been buying shares over the last 6 months. Of note, John Molbeck ,COO, bought $418K in stock on open market in August at around $27-$28 per share and during January Edward Ellis, Chief Financial Officer, exercised over $1 million in options at $18 per share and has not sold any shares after that exercise.
Finally,HCC Insurance could also become an acquisition target for a large insurance company such as AIG or foreign insurer such as Allianz, given the unique franchise HCC holds in the specialty insurance market. I would expect HCC would command a price to book value of 2x book or $42 per share if sold on a private market basis.
Disclosure: I own shares in HCC Insurance(HCC)
Disclaimer: The opinions expressed by the author’s own views and are not intended as investment advice and should not be relied upon as investment advice.
